Back
Solid Biosciences Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
SLDB
Solid Biosciences
Last Price:
10.26
Seasonality Move:
5.81%
Buy
67
CATX
Perspective Therapeutics
Last Price:
1.75
Seasonality Move:
3.58%
Buy
64
Solid Biosciences (SLDB)
is a Buy
Is Solid Biosciences a Buy, Sell or Hold?
- The current Solid Biosciences [SLDB] share price is $10.25. The Score for SLDB is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SLDB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.76. The Score for CATX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SLDB Stock Price Chart
What is Solid Biosciences's stock price today?
-
The Solid Biosciences share price today is $10.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLDB is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.76
The current trend is moderately bullish and CATX is experiencing slight selling pressure.
SLDB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 51.37 | Buy |
| Chaikin Money Flow: | -31864 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.92 - 11.1) | Buy |
| Bollinger Bands (100): | (6.79 - 11.59) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 64.38 | Buy |
| Chaikin Money Flow: | -1020082 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.46 - 1.72) | Buy |
| Bollinger Bands (100): | (0.56 - 1.44) | Buy |
SLDB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.78 | Buy |
| 20-day SMA: | 9.57 | Buy |
| 50-day SMA: | 10.97 | Sell |
| 200-day SMA: | 6.15 | Buy |
| 8-day EMA: | 9.91 | Buy |
| 20-day EMA: | 9.98 | Buy |
| 50-day EMA: | 10.1 | Buy |
| 200-day EMA: | 7.76 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.37 | Buy |
| 200-day SMA: | 0.67 | Buy |
| 8-day EMA: | 1.75 | Buy |
| 20-day EMA: | 1.64 | Buy |
| 50-day EMA: | 1.39 | Buy |
| 200-day EMA: | 0.85 | Buy |
Solid Biosciences Earnings Growth & SLDB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.22 per share, and a decrease next year of $0.65 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Solid Biosciences Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||